Datagov Opendata Platform

The Bureau of National Health Insurance has selected evidence-based medical indicators to be made public in order to enhance the quality of medical care for patients with myocardial infarction, and to serve as a reference for disease treatment and healthcare quality. The public indicators are divided into three categories based on the treatment period and quality aspects, including inpatient process assessment, assessment of continued medication after discharge, and outcome assessment. This includes the ratio of inpatients with acute myocardial infarction (AMI) who undergo LDL cholesterol testing during hospitalization, the medication ratio for AMI patients during hospitalization, and within three, six, and nine months after discharge, and the ratio of patients returning to the emergency department within three days after discharge due to the same primary diagnosis or related conditions, as well as the unplanned readmission ratio within fourteen days after discharge due to the same primary diagnosis or related conditions.